General FAQs
How much tissue is needed for the diagnosis?
In general, First Ascent requires a 5mm x 5mm live tissue section. Additional tumor material will be accepted. DNA and RNA sequencing can be performed with non-live tissue samples such as snap frozen material or FFPE tissue. Read more about the process.
When will results be available?
We aim to deliver a personalized, ranked report of the most effective drugs and combinations in 10 days, giving your doctor the clearest possible picture before making a care decision.
How much does it cost to work with First Ascent? Do you work with insurance?
Cost should never stand between a patient and the right treatment. First Ascent will be working to provide funding for patients who are struggling with finances and are unable to pay for our service.
Please contact us <crosslinks to: 7.0 Contact> or call us at 786-746-6722 for service options, pricing, and support.
In addition, several sponsored studies may help reduce or fully cover the cost for eligible participants. Explore the programs/studies <crosslinks to: 1.0 For Patients> [LS1] to learn whether you may qualify.
There are 100+ different types of cancers—which types are your platform and process a good fit for?
Our platform has been proven with many types of cancer across age groups—including tumors and blood cancers.
Since patient-specific functional testing data and DNA/RNA data are at the heart of the data sets feeding our proprietary AI, our solution can be applied to all cancer types. Our technology has worked for all 52 cancer types it has been used on and counting.
Find out more on our Resources page <links to: https://firstascentbiomedical.com/resources/>.
Where can I find out more about your clinical studies?
First Ascent Biomedical has 2 ongoing clinical studies. You can read more about NCT05857969 [LS1] and NCT06024603.
You do not need to be enrolled in a clinical study to use our proprietary testing and data. Contact us <crosslinks to: 7.0 Contact> or fill out this form to learn more.